Literature DB >> 16580600

The promise of a virtual lab in drug discovery.

Han Rauwerda1, Marco Roos, Bob O Hertzberger, Timo M Breit.   

Abstract

To date, the life sciences 'omics' revolution has not lived up to the expectation of boosting the drug discovery process. The major obstacle is dealing with the volume and diversity of data generated. An enhanced-science (e-science) approach based on remote collaboration, reuse of data and methods, and supported by a virtual laboratory (VL) environment promises to get the drug discovery process afloat. The creation, use and preservation of information in formalized knowledge spaces is essential to the e-science approach. VLs include Grid computation and data communication as well as generic and domain-specific tools and methods for information management, knowledge extraction and data analysis. Problem-solving environments (PSEs) are the domain-specific experimental environments of VLs. Thus, VL-PSEs can support virtual organizations, based on the changing partnerships characteristic of successful drug discovery enterprises.

Mesh:

Year:  2006        PMID: 16580600     DOI: 10.1016/S1359-6446(05)03680-9

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  3 in total

1.  openBIS: a flexible framework for managing and analyzing complex data in biology research.

Authors:  Angela Bauch; Izabela Adamczyk; Piotr Buczek; Franz-Josef Elmer; Kaloyan Enimanev; Pawel Glyzewski; Manuel Kohler; Tomasz Pylak; Andreas Quandt; Chandrasekhar Ramakrishnan; Christian Beisel; Lars Malmström; Ruedi Aebersold; Bernd Rinn
Journal:  BMC Bioinformatics       Date:  2011-12-08       Impact factor: 3.307

2.  SigWin-detector: a Grid-enabled workflow for discovering enriched windows of genomic features related to DNA sequences.

Authors:  Márcia A Inda; Marinus F van Batenburg; Marco Roos; Adam S Z Belloum; Dmitry Vasunin; Adianto Wibisono; Antoine H C van Kampen; Timo M Breit
Journal:  BMC Res Notes       Date:  2008-08-08

3.  Towards a unified theory of health-disease: II. Holopathogenesis.

Authors:  Naomar Almeida Filho
Journal:  Rev Saude Publica       Date:  2014-04       Impact factor: 2.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.